|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Davisite
|
172 |
62K |
7 |
14:18 |
| 14:18 |
ASX - By Stock
|
172
|
62K
|
7
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Davisite
|
172 |
62K |
2 |
14:17 |
| 14:17 |
ASX - By Stock
|
172
|
62K
|
2
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Davisite
|
172 |
62K |
2 |
13:06 |
| 13:06 |
ASX - By Stock
|
172
|
62K
|
2
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Davisite
|
172 |
62K |
1 |
10/03/26 |
| 10/03/26 |
ASX - By Stock
|
172
|
62K
|
1
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
32K |
11M |
39 |
09/03/26 |
| 09/03/26 |
ASX - By Stock
|
32K
|
11M
|
39
|
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Co-PSMA abstract released
|
|
Davisite
|
267 |
56K |
10 |
08/03/26 |
| 08/03/26 |
ASX - By Stock
|
267
|
56K
|
10
|
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Co-PSMA abstract released
|
|
Davisite
|
267 |
56K |
29 |
08/03/26 |
| 08/03/26 |
ASX - By Stock
|
267
|
56K
|
29
|
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Co-PSMA abstract released
|
|
Davisite
|
267 |
56K |
15 |
08/03/26 |
| 08/03/26 |
ASX - By Stock
|
267
|
56K
|
15
|
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Co-PSMA abstract released
|
|
Davisite
|
267 |
56K |
12 |
07/03/26 |
| 07/03/26 |
ASX - By Stock
|
267
|
56K
|
12
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
16K |
5.9M |
76 |
07/03/26 |
| 07/03/26 |
General
|
16K
|
5.9M
|
76
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Davisite
|
172 |
62K |
35 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
172
|
62K
|
35
|
|
|
ASX - By Stock
|
TCG |
Re:
Ann: S&P DJI Announces March 2026 Quarterly Rebalance
|
|
Davisite
|
8 |
1.6K |
10 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
8
|
1.6K
|
10
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
Davisite
|
377 |
102K |
45 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
377
|
102K
|
45
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix 2026 Half Year Investor Presentation
|
|
Davisite
|
151 |
32K |
18 |
05/03/26 |
| 05/03/26 |
ASX - By Stock
|
151
|
32K
|
18
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at Oppenheimer Life Sciences Conference
|
|
Davisite
|
54 |
14K |
17 |
27/02/26 |
| 27/02/26 |
ASX - By Stock
|
54
|
14K
|
17
|
|
|
ASX - By Stock
|
RAC |
Re:
(E,E)-bisantrene: Research, Reports, Markets, Competition, and Risk
|
|
Davisite
|
46 |
15K |
13 |
27/02/26 |
| 27/02/26 |
ASX - By Stock
|
46
|
15K
|
13
|
|
|
ASX - By Stock
|
RAC |
Re:
(E,E)-bisantrene: Research, Reports, Markets, Competition, and Risk
|
|
Davisite
|
46 |
15K |
48 |
27/02/26 |
| 27/02/26 |
ASX - By Stock
|
46
|
15K
|
48
|
|
|
ASX - By Stock
|
RAC |
Re:
(E,E)-bisantrene: Research, Reports, Markets, Competition, and Risk
|
|
Davisite
|
46 |
15K |
72 |
26/02/26 |
| 26/02/26 |
ASX - By Stock
|
46
|
15K
|
72
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Receives Capital Raise Commitments of A$45 Million
|
|
Davisite
|
433 |
106K |
2 |
17/02/26 |
| 17/02/26 |
ASX - By Stock
|
433
|
106K
|
2
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Receives Capital Raise Commitments of A$45 Million
|
|
Davisite
|
433 |
106K |
14 |
17/02/26 |
| 17/02/26 |
ASX - By Stock
|
433
|
106K
|
14
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Davisite
|
417 |
111K |
2 |
16/02/26 |
| 16/02/26 |
ASX - By Stock
|
417
|
111K
|
2
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Davisite
|
417 |
111K |
25 |
14/02/26 |
| 14/02/26 |
ASX - By Stock
|
417
|
111K
|
25
|
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Davisite
|
417 |
111K |
30 |
14/02/26 |
| 14/02/26 |
ASX - By Stock
|
417
|
111K
|
30
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Davisite
|
32K |
11M |
90 |
14/02/26 |
| 14/02/26 |
ASX - By Stock
|
32K
|
11M
|
90
|
|
|
ASX - By Stock
|
BM1 |
Re:
Ann: Trading Halt
|
|
Davisite
|
34 |
7.8K |
1 |
21/01/26 |
| 21/01/26 |
ASX - By Stock
|
34
|
7.8K
|
1
|
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Ongoing engagement with the US FDA
|
|
Davisite
|
30 |
8.3K |
17 |
20/01/26 |
| 20/01/26 |
ASX - By Stock
|
30
|
8.3K
|
17
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-004 phase III trial enrolment continues at robust pace
|
|
Davisite
|
18 |
11K |
2 |
21/12/25 |
| 21/12/25 |
ASX - By Stock
|
18
|
11K
|
2
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-004 phase III trial enrolment continues at robust pace
|
|
Davisite
|
18 |
11K |
15 |
19/12/25 |
| 19/12/25 |
ASX - By Stock
|
18
|
11K
|
15
|
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Agreement with Texas Biomed for Galidesivir Program
|
|
Davisite
|
8 |
3.6K |
11 |
17/12/25 |
| 17/12/25 |
ASX - By Stock
|
8
|
3.6K
|
11
|
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Agreement with Texas Biomed for Galidesivir Program
|
|
Davisite
|
8 |
3.6K |
42 |
17/12/25 |
| 17/12/25 |
ASX - By Stock
|
8
|
3.6K
|
42
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
16K |
5.9M |
33 |
10/10/25 |
| 10/10/25 |
General
|
16K
|
5.9M
|
33
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: International G4 Expert Laurence Hurley Joins Race SAB
|
|
Davisite
|
34 |
9.8K |
50 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
34
|
9.8K
|
50
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-004 (KEYNOTE-F91) Phase 3 update in First Line NSCLC
|
|
Davisite
|
7 |
3.8K |
31 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
7
|
3.8K
|
31
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
16K |
5.9M |
31 |
08/10/25 |
| 08/10/25 |
General
|
16K
|
5.9M
|
31
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RACE oncology rNPV valuation thread: RAC analytics app
|
|
Davisite
|
56 |
19K |
11 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
56
|
19K
|
11
|
|
|
ASX - By Stock
|
RAC |
Re:
Piggyback Options (RACOPT43)
|
|
Davisite
|
153 |
38K |
7 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
153
|
38K
|
7
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Anticancer MOA Webinar
|
|
Davisite
|
80 |
23K |
43 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
80
|
23K
|
43
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
Davisite
|
377 |
102K |
27 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
377
|
102K
|
27
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Anticancer MOA Webinar
|
|
Davisite
|
80 |
23K |
19 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
80
|
23K
|
19
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Anticancer MOA Webinar
|
|
Davisite
|
80 |
23K |
31 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
80
|
23K
|
31
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Online Investor Briefing Invitation
|
|
Davisite
|
23 |
7.5K |
30 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
23
|
7.5K
|
30
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Online Investor Briefing Invitation
|
|
Davisite
|
23 |
7.5K |
68 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
23
|
7.5K
|
68
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Online Investor Briefing Invitation
|
|
Davisite
|
23 |
7.5K |
113 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
23
|
7.5K
|
113
|
|
|
ASX - By Stock
|
SCN |
Re:
Ann: Response to ASX price and volume query
|
|
Davisite
|
45 |
8.5K |
7 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
45
|
8.5K
|
7
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
Davisite
|
377 |
102K |
53 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
377
|
102K
|
53
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
Davisite
|
377 |
102K |
33 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
377
|
102K
|
33
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Davisite
|
3.5K |
1.2M |
84 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
3.5K
|
1.2M
|
84
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Online Investor Briefing Invitation
|
|
Davisite
|
23 |
7.5K |
54 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
23
|
7.5K
|
54
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Online Investor Briefing Invitation
|
|
Davisite
|
23 |
7.5K |
63 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
23
|
7.5K
|
63
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Davisite
|
16K |
5.9M |
34 |
08/10/25 |
| 08/10/25 |
General
|
16K
|
5.9M
|
34
|
|